Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
Radiat Res. 2023 Mar 1;199(3):301-318. doi: 10.1667/RADE-22-00148.1.
During a radiological or nuclear public health emergency, given the heterogeneity of civilian populations, it is incumbent on medical response planners to understand and prepare for a potentially high degree of interindividual variability in the biological effects of radiation exposure. A part of advanced planning should include a comprehensive approach, in which the range of possible human responses in relation to the type of radiation expected from an incident has been thoughtfully considered. Although there are several reports addressing the radiation response for special populations (as compared to the standard 18-45-year-old male), the current review surveys published literature to assess the level of consideration given to differences in acute radiation responses in certain sub-groups. The authors attempt to bring clarity to the complex nature of human biology in the context of radiation to facilitate a path forward for radiation medical countermeasure (MCM) development that may be appropriate and effective in special populations. Consequently, the focus is on the medical (as opposed to logistical) aspects of preparedness and response. Populations identified for consideration include obstetric, pediatric, geriatric, males, females, individuals of different race/ethnicity, and people with comorbidities. Relevant animal models, biomarkers of radiation injury, and MCMs are highlighted, in addition to underscoring gaps in knowledge and the need for consistent and early inclusion of these populations in research. The inclusion of special populations in preclinical and clinical studies is essential to address shortcomings and is an important consideration for radiation public health emergency response planning. Pursuing this goal will benefit the population at large by considering those at greatest risk of health consequences after a radiological or nuclear mass casualty incident.
在放射学或核公共卫生紧急情况下,鉴于平民群体的异质性,医疗应对规划人员有责任了解并为辐射暴露的生物学效应可能存在的高度个体间差异做好准备。高级规划的一部分应包括一种全面的方法,其中应深思熟虑地考虑与预计事件中辐射类型相关的人类可能反应范围。虽然有几份报告专门针对特殊人群(与标准的 18-45 岁男性相比)的辐射反应,但本综述调查了已发表的文献,以评估在某些亚组中对急性辐射反应差异的考虑程度。作者试图在辐射背景下阐明人类生物学的复杂性,为辐射医学对策(MCM)的发展提供一个可能适用于特殊人群的并有效的途径。因此,重点是准备和应对的医学(而不是后勤)方面。确定需要考虑的人群包括产科、儿科、老年、男性、女性、不同种族/民族的个体以及患有合并症的个体。除了强调知识差距和需要在研究中尽早将这些人群纳入一致的研究之外,还突出了相关的动物模型、辐射损伤生物标志物和 MCM。将特殊人群纳入临床前和临床研究对于解决缺点至关重要,这也是辐射公共卫生应急规划的一个重要考虑因素。通过考虑那些在放射性或核大规模伤亡事件后健康后果风险最大的人群,来实现这一目标将使广大民众受益。